Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Landos Biopharma (LABP) Q3 2023 Earnings
LABP
9
Nov
Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.1
-0.76
-0.43
-0.09
Details
Expected EPS
-0.88
Actual EPS
-0.94
Surprise EPS
-0.06
Surprise Percent
+6.82%
Description
Landos Biopharma (LABP) has reported earnings of -0.94 per share for Q3 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login